James Mulheron has accepted a one-year suspension from USADA for an anti-doping violation stemming from an out-of-competition sample collected on Nov. 10.
The UFC announced the heavyweight’s sanction in a statement on Tuesday:
Mulheron, 29, tested positive for clomiphene and its metabolite, hydroxyclomiphene, following an out-of-competition urine test conducted on November 10, 2017. Clomiphene is a Specified Substance in the class of Hormone and Metabolic Modulators and is prohibited at all times under the UFC Anti-Doping Policy, which has adopted the World Anti-Doping Agency Prohibited List.
Clomiphene is not approved by the U.